Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine added to propofol in pediatric electroconvulsive therapy
IRCT20160307026950N29Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing Propofol + dexmedetomidine with Propofol + normal saline (2 arms). Primary endpoints: Heart rate changes and Changes in blood pressure. Started Dec 2020; status: completed.
02
Drugs
dexmedetomidinepropofol
Beyond the preview
Go deeper on IRCT20160307026950N29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N29.